Kenneth Lim, MD, PhD

Bio

Dr. Ken Lim, MD, PhD, MPhil, FASN, FAHA, FRCP, is an American Physician-Scientist and Nephrologist and Entrepreneur. The mission of his work is to create potential solutions to challenging issues of humanitarian need in healthcare and human suffering through innovative research, academic entrepreneurship and the delivery of medical care beyond borders. Prior to joining the faculty at IUSM in 2020, he spent ~10 years at Harvard Medical School and affiliated major teaching hospitals. From 2018 – 2020, he was appointed Attending Physician at The Massachusetts General Hospital and a Faculty Member at Harvard Medical School. He is a graduate of The University of Cambridge (Christ’s College) and The University of Warwick in England.

Dr. Lim is a clinical trialist and translational scientist with a subspecialty interest in cardionephrology. He has a special interest in the development of cardiovascular functional endpoints for regulatory efficacy trials in nephrology, solutions to methodologic challenges in cardiorenal clinical trial design and in peptidomimetics. He leads a research group at IUSM that focuses on the development and delivery of definitive clinical trials in patients with kidney failure and cardiovascular complications, and the development of advanced peptide-based therapeutics. He founded the first Cardiopulmonary Exercise Testing (CPET) laboratory dedicated to the study of patients with kidney disease in the United States. He continues to be engaged in starting new companies at the forefront of innovation to bring sustainable impact, and translational strategies for taking biological discoveries into early phase exploratory trials.

He is the recipient of the Genzyme-Sanofi Fellowship in Nephrology, ASN Carl W. Gottschalk Research Scholar award, the Young Physician–Scientist Award by the American Society of Clinical Investigation (ASCI), full membership of the Sigma Xi Scientific Research Honor Society, and the Indianapolis Business Journal (IBJ) Forty Under 40 Award among others. He has been named Fellow of the American Society of Nephrology (FASN), Fellow of the American Heart Association (FAHA) and Fellow of the Royal College of Physicians (FRCP). He has served as strategic advisor or consultant to leaders from diverse sectors, he has held offices of leadership on numerous boards and has appeared on various television and media programs.